Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3250939
Max Phase: Preclinical
Molecular Formula: C48H68N14O11
Molecular Weight: 1017.16
Molecule Type: Protein
Associated Items:
ID: ALA3250939
Max Phase: Preclinical
Molecular Formula: C48H68N14O11
Molecular Weight: 1017.16
Molecule Type: Protein
Associated Items:
Canonical SMILES: CNCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc([N+](=O)[O-])cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C
Standard InChI: InChI=1S/C48H68N14O11/c1-27(2)39(59-41(64)33(55-38(63)25-51-5)13-9-19-53-48(49)50)44(67)56-34(21-30-15-17-32(18-16-30)62(72)73)42(65)60-40(28(3)4)45(68)57-35(23-31-24-52-26-54-31)46(69)61-20-10-14-37(61)43(66)58-36(47(70)71)22-29-11-7-6-8-12-29/h6-8,11-12,15-18,24,26-28,33-37,39-40,51H,9-10,13-14,19-23,25H2,1-5H3,(H,52,54)(H,55,63)(H,56,67)(H,57,68)(H,58,66)(H,59,64)(H,60,65)(H,70,71)(H4,49,50,53)/t33-,34-,35-,36-,37-,39-,40-/m0/s1
Standard InChI Key: XDDPNZQTURWPON-AOEIQLFRSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1017.16 | Molecular Weight (Monoisotopic): 1016.5192 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Escher EH, Guillemette G.. (1979) Photoaffinity labeling of the angiotensin II receptor. 3. Receptor inactivation with photolabile hormone analogues., 22 (9): [PMID:226704] [10.1021/jm00195a007] |
2. Escher EH, Nguyen TM, Robert H, St-Pierre SA, Regoli DC.. (1978) Photoaffinity labeling of the angiotensin II receptor. 1. Synthesis and biological activities of the labeling peptides., 21 (9): [PMID:214562] [10.1021/jm00207a004] |
Source(1):